Colorectal panel provides detailed cancer information: Rondell Graham, M.B.B.S.
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new colorectal cancer panel. The assay covers more genes to better inform decision-making about prognosis, targeted therapies and a hereditary cancer syndrome.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:32)
Could you provide us a little background about yourself?
(01:44)
Could you give us a brief overview of the new Mayo complete colorectal panel assay?
(03:44)
Can you go a little bit into more detail on guidelines and therapeutic implications concerning these specific genes?
(06:09)
Which patients should have this testing?
(08:00)
Are there any last pieces you'd like to add about the new Mayo Clinic colorectal cancer assay?